Literature DB >> 11268338

Contribution of differently localized alpha 2- and beta-adrenoceptors in the modulation of TNF-alpha and IL-10 production in endotoxemic mice.

J Szelényi1, J P Kiss, E Puskás, M Szelényi, E S Vizi.   

Abstract

Evidence is presented that the immune response to endotoxemia is under tonic control of the sympathetic nervous system. Adrenergic agents may influence the immune response both directly through alpha- and beta-adrenergic receptors expressed by immunologically competent cells and indirectly via alteration of the endogenous NA level by influencing the activity of release-regulating presynaptic alpha 2-adrenoceptors located on the sympathetic nerve terminals. In the immunomodulatory effect of NA/adrenergic drugs, their action on beta-adrenoceptors was dominant, but the considerable role of alpha-adrenoceptors on macrophages was also demonstrated. According to our findings, regulation of the ascending wing of the inflammatory response, that is, TNF-alpha production, is more sensitive to the adrenoceptor effect, whereas modulation of its deregulation by IL-10 production also involves some other determining factors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11268338     DOI: 10.1111/j.1749-6632.2000.tb05378.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  14 in total

Review 1.  Biobehavioral influences on cancer progression.

Authors:  Erin S Costanzo; Anil K Sood; Susan K Lutgendorf
Journal:  Immunol Allergy Clin North Am       Date:  2011-02       Impact factor: 3.479

Review 2.  Role of nonsynaptic communication in regulating the immune response.

Authors:  Zsolt Selmeczy; E Sylvester Vizi; Balázs Csóka; Pál Pacher; György Haskó
Journal:  Neurochem Int       Date:  2007-06-17       Impact factor: 3.921

3.  Activation of Hippocampal CREB by Rolipram Partially Recovers Balance Between TNF-α and IL-10 Levels and Improves Cognitive Deficits in Diabetic Rats.

Authors:  Ya Miao; Ting He; Yitong Zhu; Wei Li; Beiyuan Wang; Yuan Zhong
Journal:  Cell Mol Neurobiol       Date:  2015-05-23       Impact factor: 5.046

4.  Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma.

Authors:  Susan K Lutgendorf; Donald M Lamkin; Nicholas B Jennings; Jesusa M G Arevalo; Frank Penedo; Koen DeGeest; Robert R Langley; Joseph A Lucci; Steve W Cole; David M Lubaroff; Anil K Sood
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

5.  The ceramide-1-phosphate analogue PCERA-1 modulates tumour necrosis factor-alpha and interleukin-10 production in macrophages via the cAMP-PKA-CREB pathway in a GTP-dependent manner.

Authors:  Dorit Avni; Amir Philosoph; Michael M Meijler; Tsaffrir Zor
Journal:  Immunology       Date:  2009-11-16       Impact factor: 7.397

Review 6.  Nerve Stimulation: Immunomodulation and Control of Inflammation.

Authors:  Luis Ulloa; Salvador Quiroz-Gonzalez; Rafael Torres-Rosas
Journal:  Trends Mol Med       Date:  2017-11-20       Impact factor: 11.951

7.  Reflex control of inflammation by sympathetic nerves, not the vagus.

Authors:  D Martelli; S T Yao; M J McKinley; R M McAllen
Journal:  J Physiol       Date:  2014-01-13       Impact factor: 5.182

8.  Multiple G-protein-coupling specificity of beta-adrenoceptor in macrophages.

Authors:  Maria Magocsi; E Sylvester Vizi; Zsolt Selmeczy; Anna Brózik; Judith Szelenyi
Journal:  Immunology       Date:  2007-10-19       Impact factor: 7.397

9.  The effect of clonidine on VEGF expression in human retinal pigment epithelial cells (ARPE-19).

Authors:  Kazuhiko Watanabe; Xue-Yun Zhang; Kiyotaka Kitagawa; Tatsuya Yunoki; Atsushi Hayashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-15       Impact factor: 3.117

10.  Differential contribution of beta-adrenergic receptors expressed on radiosensitive versus radioresistant cells to protection against inflammation and mortality in murine endotoxemia.

Authors:  Jill Walker-Brown; Margo R Roberts
Journal:  Shock       Date:  2009-11       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.